Sensitivity analysis Pooling the available adjusted HRs for statin use and DFS showed a trend towards improved DFS, however, not significant (HR = 0.86, 95% CI: 0.74–1.01, I 2 : 0%).
← all excerpts
The impact of statins on prognostic outcomes in patients with non-metastatic solid cancers: a systematic review and meta-analysis.
1
—
—